Repligen (RGEN) Accumulated Expenses (2011 - 2026)

Repligen (RGEN) has reported Accumulated Expenses for 16 consecutive years, with $77.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Accumulated Expenses rose 1.19% year-over-year to $77.1 million; the TTM figure through Jun 2026 stood at $77.1 million (up 1.19% YoY), while the FY2025 annual figure was $79.2 million, up 26.89% from the prior year.
• Accumulated Expenses advanced to $77.1 million in Q2 2026 per RGEN's latest filing, from $65.3 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $79.2 million in Q4 2025 and bottomed at $57.3 million in Q4 2023.
• Historically, Accumulated Expenses has averaged $67.7 million across 5 years, with a median of $67.3 million in 2023.
• Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 53.47% — and 2023, when it slipped 22.13%.
• Repligen's Accumulated Expenses stood at $71.1 million in 2022, then fell by 19.41% to $57.3 million in 2023, then rose by 8.92% to $62.4 million in 2024, then rose by 26.89% to $79.2 million in 2025, then fell by 2.69% to $77.1 million in 2026.
• Business Quant data shows RGEN's Accumulated Expenses at $77.1 million in Q2 2026, $65.3 million in Q1 2026, and $79.2 million in Q4 2025.